Join AMCP for a review of the provisions contained in the proposed Contract Year 2021 and 2022 Medicare Advantage and Part D rule that was released by the Centers for Medicare and Medicaid Services (CMS) on February 5, 2020. This webinar will take a deep dive into the policy provisions of importance to managed care pharmacy including pharmacy performance standards, specialty tier composition, real time benefit tools, continued implementation of opioid management programs, and more. Please join us and help inform AMCP’s comments to CMS!


  • Carrie Monks
    Director, Regulatory Affairs
    Academy of Managed Care Pharmacy (AMCP)
  • Ross Margulies
    Foley Hoag LLP
** IMPORTANT: AMCP webinars are limited to the first 1000 that join the webinar. AMCP will provide a link to the recording and slides to all registrants within one week from the webinar date.

Click here for additional information and registration details.

Related Content

Evidence Matters 2022

Evidence Matters 2022

Evidence Matters is a virtual one-day summit that brings the literature review community together from different industries to learn, engage, and solve ever-pressing evidence-based research challenges.